Medicine and Dentistry
Cancer Treatment
86%
Meta-Analysis
60%
Prostate Cancer
60%
Radiation Therapy
53%
Malignant Neoplasm
43%
Clinical Research
43%
Disease
37%
Clinical Trial
35%
Androgen Deprivation Therapy
26%
Hodgkin's Lymphoma
26%
Progression Free Survival
26%
Overall Survival
25%
Pooled Analysis
24%
Soft Tissue Sarcoma
24%
Childhood Cancer
24%
Cancer Registry
24%
Osteosarcoma
24%
Arm
24%
Adriamycin Bleomycin Vinblastine Dacarbazine
21%
Diagnosis
21%
Hazard Ratio
21%
Neoplasm
20%
Polyethylene Terephthalate
17%
Breast Cancer
16%
Radiation Dose Escalation
16%
Prostate Specific Antigen
15%
Phase II Trials
15%
Survival Rate
14%
Patient-Data
14%
Diagnostic Test
14%
Chemotherapy
14%
Symptomatic Treatment
13%
External Beam Radiotherapy
13%
Leiomyosarcoma
13%
Cohort Analysis
13%
Distant Metastasis
12%
Acute Kidney Injury
12%
Clinical Trial Design
12%
Metastatic Kidney Cancer
12%
Sunitinib
12%
Nephrectomy
12%
Androgen Suppression
12%
Plasma Cell Granuloma
12%
Post-Hoc Analysis
12%
Colorectal Liver Metastasis
12%
Schistosoma Mansoni
12%
Systematic Review
12%
Anaplastic Lymphoma Kinase
12%
Male Breast Cancer
12%
Surgery
12%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Prostate Cancer
48%
Clinical Trial
30%
Overall Survival
27%
Androgen
26%
Progression Free Survival
26%
Cancer Registry
24%
Sustained Release
24%
Flucytosine
24%
Bioavailability
24%
Osteosarcoma
24%
Soft Tissue Sarcoma
24%
Prevalence
23%
Disease
22%
Prostate Specific Antigen
18%
Phase II Trials
15%
Survival Rate
14%
Leiomyosarcoma
13%
Tablet
13%
Cohort Study
13%
Malnutrition
12%
Clinical Research
12%
Normal Human
12%
Crizotinib
12%
Plasma Cell Granuloma
12%
Hospital Mortality
12%
Hepatitis B
12%
Sunitinib
12%
Nivolumab
12%
Stillbirth
12%
Kidney Cancer
12%
Synovial Sarcoma
12%
Liposarcoma
12%
Cryptococcal Meningitis
12%
Randomized Clinical Trial
12%
Microfilariasis
12%
Metastasis Free Survival
12%
Loiasis
12%
Carcinoma
12%
Anaplastic Lymphoma Kinase
12%
Anticonvulsive Agent
12%
Clinical Trial Design
12%
Distant Metastasis
12%
Psychotropic Agent
12%
Acute Kidney Failure
12%
Congenital Malformation
12%
Adverse Event
9%
Breast Cancer
8%
Distant Metastasis Free Survival
7%
Pharmacokinetics
7%